CRISPR and Vertex Pharmaceuticals developed the CASGEVY therapy, noting growing treatment centers in Europe and the US.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CRISPR and Vertex Pharmaceuticals developed the CASGEVY therapy, noting growing treatment centers in Europe and the US.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CRISPR Therapeutics
company in Basel, Switzerland
Nothing else this week.
-
Vertex Pharmaceuticals
American pharmaceutical company
Related events
- CRISPR Therapeutics and Vertex Pharmaceuticals split profits and costs for Casgevy, while CRISPR plans to present pipeline data at the AHA meeting.
- CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy Casgevy for sickle cell disease.
- CRISPR Therapeutics formed a strategic partnership with Vertex Pharmaceuticals.
- CRISPR Therapeutics, Eli Lilly, and Johnson & Johnson are noted as major holdings in health care ETFs.
- CRISPR Therapeutics presented clinical data at the American Society of Hematology meeting on November 4, 2026.